The percentage blood volume occupied by red blood cells is known as haematocrit. While it is straightforward to measure haematocrit in large arteries, it is very challenging to do it in microvasculature (cerebral haematocrit). Currently, this can only be done using invasive methods (e.g. PET), but their use is very limited. Local variations in cerebral haematocrit have been reported in various brain abnormalities (e.g. stroke, tumours). We propose a new approach to image cerebral haematocrit using MRI, which relies on combining data from two measurements: one that provides haematocrit-weighted and other one haematocrit-independent values of the same parameter, thus providing an easily obtainable measurement of this important physiological parameter. Four different implementations are described, with one illustrated as proof-of-concept using data from healthy subjects. Cerebral haematocrit measurements were found to be in general agreement with literature values from invasive techniques (e.g. cerebral/arterial ratios of 0.88 and 0.86 for sub-cortical and cortical regions), and showed good test-retest reproducibility (e.g. coefficient-of-variation: 15% and 13% for those regions). The method was also able to detect statistically significant haematocrit gender differences in cortical regions (p < 0.01). The proposed MRI technique should have important applications in various neurological diseases, such as in stroke and brain tumours.
Introduction
Red blood cells (or erythrocytes) carry oxygen from the lungs to the tissues and transport carbon dioxide back to the lungs. The percentage of the total blood volume occupied by red blood cells is known in physiology as the haematocrit (Hct). While it is straightforward to measure the haematocrit in large arteries (e.g. by centrifuging a blood sample), it is much more challenging to obtain it in the cerebral microvasculature. As shown by many studies, 1-7 the cerebral haematocrit differs from the large vessel haematocrit (with a smaller value in the microvasculature, e.g. the 'classical' arterial/tissue haematocrit ratio value of 0.85), 1, 2, 7 due to differences in velocity of blood plasma and the red blood cells residing in it (an effect known as the Fahraeus effect). 2 Currently, only invasive methods have been proposed to measure the small vessel or cerebral haematocrit (Hct brain or Hct tissue , i.e. haematocrit values of blood within small arterioles, venules and capillaries of the brain). Available approaches are based upon positron emission tomography (PET), single photon emission computer tomography (SPECT), and autoradiography, 1, 2, 8, 9 but their use is very limited due to their invasive nature and the poor availability of suitable radiotracers. The limited number of prior cerebral Hct mapping studies have, however, shown that the grey matter-white matter contrast is much lower than that seen in cerebral blood flow (CBF) and cerebral blood volume (CBV) maps, 1, 2, 4, 5, 7 and there have been limited reports of higher Hct tissue values in basal ganglia 5 and no rightleft hemispheric asymmetry [3] [4] [5] [6] (although, one report 2 did show lower Hct tissue values in the left hemisphere, in a sample of 10 healthy right-handed subjects).
Cerebral haematocrit changes have been shown to directly influence the resistance of the microcirculation, and local variations have been reported in various brain abnormalities, [3] [4] [5] [6] [7] 10, 11 such as increased values in acute stroke, 3, 6 decreased values in chronic arterial occlusion, 4, 5 decreased values in the contralateral cerebellar cortex in crossed cerebellar diaschisis, 10 both increased and decreased values in brain tumours (likely due to the wide range of abnormal vasculature that can be found in different tumours), 7 as well as reduced values during hypercarbia. 2 Although haematocrit changes are known to affect rheological properties of blood and that rheological disorders within the microcirculation are known to play a significant role in various diseases, the clinical importance of these effects has not yet been fully established. This gap of knowledge can be directly attributed to the absence of easily applied measurement techniques, thereby limiting the clinical research on this topic.
In addition to the clinical potential of a cerebral haematocrit imaging method, knowledge on small vessel haematocrit is also important for several perfusion imaging methods that aim to quantify cerebral blood flow (CBF). 12, 13 For example, assumptions on the cerebral haematocrit are necessary in cerebral perfusion measurements using MRI and computed tomography (CT), since the extracellular contrast agents that are applied in these techniques are transported within the blood plasma making these techniques sensitive to plasma flow rather than total blood flow. In practice, any technique that requires knowledge of local cerebral haematocrit levels, therefore, commonly relies on assuming a single uniform value (taken from published literature, such as Hct in capillaries ¼ 0.25) 14 for the whole brain, regardless of the tissue type or particular patient; this can naturally lead to erroneous measurements. A more detailed characterisation of tissue haematocrit values could be used to better inform DSC-MRI and perfusion CT quantification (e.g. via the use of more detailed look-up tables rather than a uniform value for every voxel and every subject).
In this study, we propose a novel approach to image local cerebral haematocrit levels using MRI. The proposed method relies on combining haemodynamic data obtained from two MRI measurements: one that provides haematocrit-weighted values, and another one that provides haematocrit-independent values of the same parameter. By combining these two measurements, it is possible to isolate the local cerebral haematocrit information, thus providing an easily obtainable and minimally invasive measurement of this important physiological parameter.
Material and methods
Because MRI offers many different approaches to probe cerebral perfusion, there are various ways to combine MRI measurements to measure cerebral haematocrit. We describe here a particular implementation for which we also demonstrate, as proof-ofconcept, in vivo results from a group of subjects; we refer to this implementation as Case 1 hereafter. Please refer to Appendix 1 for three further alternative implementations.
Case 1 implementation is based on combining data from (i) a dynamic susceptibility contrast (DSC) MRI study in absolute units and (ii) an arterial spin labelling (ASL) study. It assumes that the DSC-MRI data can provide measurements in absolute units. This, for example, requires that the arterial input function (AIF) is measured in absolute units. 15 This can be achieved, for example, by acquiring the DSC-MRI data using the method proposed by Kellner et al., 16 or by correcting the partial-volume-effect using postprocessing methods, such as those proposed by van Osch et al. 17 and Knutsson et al. 18 In this case, a deconvolution analysis 14 of the DSC-MRI data provides a Hct-weighted CBF (CBF Hct ) in absolute units, i.e. CBF DSC-MRI ¼CBF Hct , which can be explicitly written as 14
where
and V plasma [Á] is the relative plasma volume.
It should be noted that, in most DSC-MRI studies, a given value for the proportionally constant k Hct is assumed (either by assuming literature values for the Hct levels in the tissue and the artery, or simply by setting it to 1) and, therefore, the variations in Hct are most often disregarded in DSC-MRI studies. In fact, the Hct-weighting is usually considered a nuisance in DSC-MRI, but its presence is central to the method proposed here.
From a complementary ASL measurement, which is known to provide absolute CBF measurements (i.e. CBF ASL ¼CBF), one can calculate k Hct as the CBF ratio
Therefore, we get the local cerebral Hct as
where Hct art is the haematocrit measured in a large artery. In summary, from a DSC-MRI study in absolute units, combined with an ASL study and an arterial Hct value (such as that measured from a blood sample; or from an assumed literature value, if a blood sample is not available), the proposed method provides a means to calculate a map of local cerebral Hct (using equation (4)). Three alternative possible implementations of the Hct mapping method are described in Appendix 1, which are based on various types of CBV measurements -see Appendix 1 for theoretical formulas and details.
MRI experiments
As illustration of the Case 1 implementation, cerebral haematocrit measurements were carried out in a group of healthy subjects. Furthermore, to investigate the reproducibility, the subjects were scanned on two occasions.
Twenty healthy subjects (age range: 24-84, 10 females) were scanned twice each (with a time interval of 7-20 days between investigations) on a 3T MRI scanner (Philips Achieva, Philips Medical Systems, Best, The Netherlands); ASL and DSC-MRI data were acquired in each session. The project was approved by the Lund University regional ethical review board (following the ethical guidelines of the Helsinki Declaration of 1975 (and as revised in 1983)), and each subject gave written confirmed consent to participate in the study. All brain scans were considered normal by an experienced neurologist. Four ASL scans (from a total of 3 subjects) suffered from incomplete labelling of blood water (manifested as complete loss of ASL signal in a given vascular territory) and these studies were omitted from this proof-ofconcept study.
Dynamic susceptibility contrast MRI. To obtain quantitative CBF measurements by DSC-MRI, the so-called prebolus method was applied in which a separate injection of contrast agent allows for a quantitative measurement of the venous output function (VOF) by adjusting the MRI sequence parameters. 18 For proper planning of this DSC-MRI pre-bolus experiment, a sagittal phase contrast angiography T 1 -FFE scan was performed (relevant parameters: 300 Â 300 mm 2 fieldof-view, 256 Â 256 matrix, 50 mm slice thickness, 1.17 Â 1.17 mm 2 in plane resolution, 15 flip angle, TE/TR ¼ 5.68/20 ms, and two averages). In order to achieve similar planning for both experiments, the planning from the first experiment was saved and thereafter used for the planning of the second experiment. The planning of the actual DSC-MRI scan was performed using the Philips automatic planning tool SmartExam in order to minimise user interaction.
A pre-bolus of contrast agent (Dotarem, Guerbet, Paris, France) was administered (0.02 mmol/kg, injection rate 5 ml/s) and a segmented echo planar imaging (EPI) was used to track the pre-bolus passage through the sagittal sinus in one single slice using a temporal resolution of 0.81 s. The imaging parameters were as follows: 220 Â 220 mm 2 field-of-view, 128 Â 128 matrix, 5 mm slice thickness, 1.72 Â 1.72 mm 2 in-plane resolution, EPI factor 7, 22 flip angle, TE/TR ¼ 15/135 ms, acquisition time 98 s. In-plane PVE can be considered minimal given the much larger diameter of the sagittal sinus (mean diameter ranges from 4.3mm in the mid-anterior frontal region to 9.9mm in the midoccipital region) 19 ; through-plane PVE was minimised by choosing the slice orientation approximately perpendicular to the sagittal sinus, in a section where this vein has a relatively large diameter. After the pre-bolus scan, a normal single dose of the contrast agent (0.1 mmol/ kg) was administered at an injection rate of 5 ml/s, and the actual DSC-MRI experiment was performed using a single-shot gradient-echo EPI with the following imaging parameters: 220 Â 220 mm 2 field-of-view, 128 Â 128 matrix, 5 mm slice thickness, 1.72 Â 1.72 mm 2 in-plane resolution, 20 slices, 60 flip angle, TE/TR ¼ 29/1243 ms, acquisition time 91 s. Each bolus injection was followed by a 20 ml saline flush injected at the same rate as the contrast agent.
Arterial spin labeling. ASL was carried out using a pseudo-continuous ASL (pCASL) sequence, which included a 1600 ms post-labelling delay to minimize sensitivity to transit time, and background suppression inversion pulses at 1710 and 2860 ms after a prelabelling saturation pulse to increase the signal-tonoise ratio in the perfusion weighted images. The image read-out was performed using single-shot EPI in combination with parallel imaging (96 Â 96 matrix, 5 mm slice thickness, 1 mm slice gap, 2.29 Â 2.29 mm 2 reconstructed in-plane resolution, 16 slices, EPI factor 37, 90 flip angle, TE/TR ¼ 14/4000 ms, 1650 ms label duration, 20 mm label gap, 30 repetitions, and SPIR fat suppression, total acquisition time 240 s). A reference scan for M 0 calibration was performed using a sequence identical to the pCASL, except that labelling and background suppression were turned off, TR ¼ 10 s, and the number of repetitions was 4, total acquisition time 40 s.
Post-processing
Dynamic susceptibility contrast MRI. The AIF was measured by using a semi-automatic method, as previously described in Knutsson et al. 18 Absolute CBF was then obtained by scaling the measured AIF by the time integral of the VOF (the pre-bolus VOF area was multiplied by five, i.e. 0.1/0.02, to obtain the same VOF area as would have been observed for a normal dose), measured in the sagittal sinus during the pre-bolus experiment. 18 Deconvolution was done using the block-circulant singular value decomposition method, 20 to obtain a Hct-weighted CBF estimate in ml/100g/min 14
where R(t) is the tissue residue function, and is the brain parenchyma mass density (set to 1.04 g/ml).
Arterial spin labelling. The pCASL signal depends primarily on the CBF, the efficiency with which the inflowing blood is labelled, the rate at which the label decays, and the sensitivity of the scanner to the label. The labelling efficiency was estimated as the combined effects of inversion efficiency at the labelling site and the effective spoiling of labelled spins due to the background suppression pulses. This total labelling efficiency was assumed to be 70%. 21 The arterial blood was assumed to have a longitudinal relaxation time (T 1a ) of 1.65 s. 22 The equilibrium blood magnetization (M 0,a ) was estimated by using the intensity of white matter (WM) as a calibration standard. For each subject, a binary WM mask was automatically produced by thresholding the segmented WM tissue probability map at 95%, and the average intensity in the reference image within this region was calculated. This mean WM intensity was used as a measure of the equilibrium magnetization of WM, M 0,WM . Correction for water content and transverse relaxation effects (compared to arterial blood) yield the M 0,a estimation according to
where i is the fractional volume water content of compartment i, T Ã 2i is the effective transverse relaxation time of compartment i, and is the brain density in g/ml.
Quantification was done using a model resembling the recommendations of the recent ASL consensus article 23
where is the total labeling efficiency, f is perfusion, is the labeling duration, and w is the post-labelling delay. The post-labelling delay is unique for every slice according to w ¼ w ps þ n slice À 0:5 ð ÞÂt ro , where w ps is the preset post-labelling delay, n slice is the slice number and t ro is the slice read-out time. Perfusion values were estimated using the model stated above, and multiplied by a factor of 6000 to obtain values in ml/100g/min. Parameters , a , WM , T Ã 2a , and T Ã 2WM were taken from the literature as 1.04 g/ml, 14 87%, 24 73%, 24 43.6 ms, 25 and 44.7 ms, 25 respectively.
Hct mapping. Haematocrit-weighted CBF (from DSC-MRI) and Hct-independent CBF (from ASL) were calculated as described above. All CBF-maps were nonlinearly co-registered (spatially normalized) to the MNI152 template brain (ICBM, NIH P-20 project) using SPM8 (http://www.fil.ion.ucl.ac.uk/spm/ software/spm8/). Local cerebral haematocrit was estimated using Case 1, according to equation (4) . Since no measurement of blood haematocrit was available, the arterial haematocrit was set to 0.45. 26 Therefore, it should be noted that any results reported here of Hct tissue in absolute values have an underlying assumption on the arterial haematocrit (please refer to Discussion for details on the limitations of the current study). Furthermore, to investigate the sensitivity to the assumed Hct art values, the analysis was repeated for values ranging from 0.3 to 0.6. Finally, to investigate the gender differences in cerebral haematocrit, Hct ratio values were calculated for male and female subjects separately. Given the known gender differences in arterial haematocrit, 26 the gender analysis was also repeated, but assuming Hct art ¼ 0.45 for the male subjects and 0.40 for females.
To characterize the representative cerebral haematocrit values in normal healthy subjects, the normalized CBF maps were used to calculate the population average Hct tissue map. It should be noted, however, that artefacts in either DSC-MRI or pCASL will introduce unrealistic haematocrit values (e.g. negative or larger than 100%). In particular, both underestimation of white matter perfusion in ASL, overestimation of perfusion close to large vessels in DSC-MRI, and CSF areas were found to lead to severely underestimated haematocrit values (see Figure 1 ). The quantitative analysis was therefore restricted to manually defined regions of interest in cortical matter and subcortical structures. Furthermore, voxels with negative Hct tissue values (for any Hct art case) were excluded from the analysis. The total number of voxels excluded from the analysis was $50% of the intracranial voxels (see Discussion section for possible ways to minimise this number by improved white matter measurements and reduced microvasculature contamination).
To assess the test-retest reproducibility, the data from the two scans (for the 17 subjects with two successful ASL scans) were displayed in a Bland-Altman plot (difference values vs. mean values), characterised by its bias (mean difference) and limit-of-agreement (mean AE 1.96 standard deviation). Another commonly used and related measure, the repeatability coefficient (CR¼ˇ2 Â 1.96 Â S w , where S w is the within-subject standard deviation), was also calculated as a measure of test-retest reliability. Finally, the coefficient of variation (CoV), defined as the standard deviation divided by the mean Hct tissue , was also computed. Figure 1 shows the CBF maps calculated using DSC-MRI and ASL on an illustrative subject. The figure also includes the computed Hct tissue maps using equation (4) . Arrows in this figure illustrate regions with severely underestimated Hct values, corresponding to large vessel artifacts in the DSC-MRI map (top row), and areas with spuriously low CBF in the ASL map (middle row); both cases lead to very low Hct estimates (bottom row). Figure 2 shows the corresponding population average results, including the average CBF maps (calculated using both DSC-MRI and ASL) and the average Hct tissue maps. Figure 2 shows the population average results, including the average CBF maps (calculated using both DSC-MRI and ASL) and the average Hct tissue maps.
Results
To get a more comprehensive visualization of the cerebral Hct results, Figure 3 shows the population average Hct tissue maps in MNI space, in three orthogonal projections.
Supplementary Figure 1 shows the manually defined cortical and subcortical regions used for the quantitative analysis. The mean (AEstandard deviation) CBF DSC-MRI values were 72.6 AE 21.5 and 76.8 AE 13.0 ml/100g/min for the sub-cortical and cortical regions, respectively; the corresponding values for CBF ASL were 65.7 AE 16.8 and 69.3 AE 11.1 ml/100g/min. Assuming a Hct art ¼0.45, the mean (AEstandard deviation) cerebral Hct values were 0.395 AE 0.060 and 0.387 AE 0.040 for the sub-cortical and cortical regions, respectively (corresponding to mean Hct tissue /Hct art ratios of 0.88 and 0.86, respectively); this regional difference in Hct values did not, however, reach statistical significance.
To characterise the dependency of the cerebral Hct on the assumed arterial Hct values, Figure 4 shows the cerebral-to-arterial Hct ratio in subcortical and cortical regions, as a function of Hct art . The figure also shows the overall variability (characterised by the standard deviation of the ratio, calculated over all 36 individual measurements) from both regions. There was no statistical significant difference between the Hct measurements of the two scanning sessions (p > 0.2, paired two-sided Wilcoxon signed rank test). Figure 5 shows the results of the reproducibility analysis in form of Bland-Altman plots. Table 1 lists the bias (i.e. mean difference), the magnitude for the limits-of-agreement (i.e. 2 Â 1.96 standard deviation), the CR, and the CoV values for the subcortical and cortical structures. This table also shows the corresponding values for the underlying perfusion MRI data used to calculate Hct tissue . Figure 6 shows the results for the gender differences for both cortical and subcortical regions in form of box-and-whisker plots, based on an assumed Hct art ¼ 0.45. The cerebral Hct ratio (relative to Hct art ) was higher in males. Based on a Mann-Whitney U-test, this gender difference was statistically significant in cortical regions (p < 0.01), but did not reach significance in subcortical structures. The corresponding results for the case of an assumed gender-dependent Hct art (0.45 for males and 0.40 for females) 26 are shown in Supplementary  Figure 2 . Given the complexities of interpreting Hct ratio differences when using a non-uniform Hct art , Supplementary Figure 3 includes the Hct tissue results separately. For the ratio results, significant differences were detected in the cortex (p < 0.01), while significant Hct tissue differences were detected for both cortical (p < 0.0001) and subcortical (p < 0.05) regions. 
Discussion
A new approach to image cerebral haematocrit using MRI was proposed. The method relies on combining MRI data from two separate measurements, one that provides Hct-weighted values and another that provides corresponding Hct-independent values. Various possible implementations of the method were described and, as proof-of-concept, in vivo data from a group of healthy subjects were presented for the particular implementation that relies on data from DSC-MRI and ASL (Case 1).
Comparison to literature
The cerebral Hct maps are visually consistent with previously reported results using invasive methods in healthy subjects, 1,2 including a much lower grey matter-white matter contrast than that seen in our CBF maps calculated from DSC-MRI and ASL. There was also a trend for an increased Hct tissue values in subcortical structures, consistent with a small increase detected in a previous report, 5 although this did not reach significance in our data. As expected from theory (e.g. see equation (4)), the quantitative results for both Hct tissue and Hct tissue /Hct art are dependent on the assumed arterial Hct value (Note: for the current study, no blood samples were available). Nevertheless, the results from Figure 4 show that the cerebral-to-arterial Hct ratio is, in general, consistent with literature values, including with the 'classical' 0.85 haematocrit ratio value. 1, 2, 7 Note, however, that there is no overall consensus regarding the exact value for this ratio, with some studies reporting lower ratios (mean values between 0.69 and 0.76) 1,2,6,7 while other higher ratios (mean values between 0.88 and 0.93). 4,5
Reproducibility
The method was shown to have reasonably good testretest reproducibility (CoV$15%). Despite the method relying on relatively noisy perfusion MRI measurements (for the Case 1 reported here), as well as the results shown here based on data not specifically optimised for Hct mapping, the Hct reproducibility was comparable to that of the underlying perfusion MRI data (CoV$12-19%), suggesting that the proposed formalism does not lead to a major noise amplification. In fact, the CoV for Hct mapping was far better than that predicted solely from propagation of errors (see Appendix 1), where the CoVs from the two CBF methods would be expected to add up to lead to a larger CoV for Hct mapping. This, however, only accounts for the variance of the data associated with Gaussian random noise, and not of other sources of variance in the data. For example, if there are any global effects (e.g. some subjects in the group have much higher/ lower CBF values than the typical average valuesnot an uncommon situation), this would be reflected Figure 6 . Characterisation of gender differences for Hct tissue /Hct art ratio for cortical (right) and subcortical (left) regions. A value of Hct art ¼ 0.45 was assumed for the arterial Hct. The line inside each box is the median, the edges of each box are the first and third quartiles, the whiskers stretch out to the most extreme values (excluding outliers), and the crosses shows automatically identified outliers. Significant gender differences were found in cortical regions, with the corresponding p-value indicated in the plot. F: female; M: male. both in the DSC-MRI and ASL CBF measurements (both CBF measurements can be considered, to some extent, correlated). While this would increase their variance, the situation is different for Hct mapping: this method is based on the CBF ratio (see equation (4)), and therefore this effect will tend to cancel out, thus decreasing the variance. The same situation applies to the other implementations (Cases 2-4), given that they are based on a CBV ratio. Taking together, all these findings suggest that Hct tissue measurements are actually much more stable than could have been initially expected purely from propagation of errors, and they have a precision similar to that of the input CBF or CBV maps.
Gender effects
Gender differences in Hct ratio were found in cortical regions, which remain significant regardless of whether the Hct art values were assumed to be gender dependent (as suggested by literature) 26 or uniform, suggesting that the Hct tissue gender difference was not due to the assumed Hct art values. Gender differences were also observed in subcortical structures, but these did only reach significance when measured as Hct tissue and assuming a gender-dependent Hct art value. This highlights that subject-specific Hct art measurements should be carried out, and that the current gender results should be taken with caution given the assumptions involved. While gender differences in arterial haematocrit are well documented, 26 the differences within the brain are not well characterised. The techniques introduced here could open up the way to future studies to further our understanding of the regional, gender, and age variations in cerebral Hct. Given that decreased Hct are associated with increased CBF, 27, 28 non-invasive cerebral Hct mapping methods should prove valuable for clinical and neuroscience investigations.
Practical considerations
A number of practical issues need to be taken in to account. First, the method relies on accurate registration between two MRI measurements, e.g. ASL and DSC-MRI data for Case 1. This not only includes rigid body registration but, ideally, it should include also matching for susceptibility-related distortions. Any mismatch between these data will lead to errors in Hct mapping. Therefore, the use of the same acquisition sequence or the use of distortion correction methods 29 is preferable to avoid this source of error. In particular, the same bandwidth-per-pixel for all acquisitions (e.g. the same echo-train inter-echo spacing) should be selected in order to ensure the same level of geometric distortion. Alternatively, one could consider the use of distortion correction based on, for example, the acquisition of a separate B 0 -map. Second, for a more robust quantification in cortical structures, the macrovascular contributions should be minimised. For DSC-MRI, this could be achieved by using a spin-echo based acquisition 14 or by removing the macrovascular contribution during post-processing. 30 Similarly, for ASL data, the macrovascular contribution can be minimised by using long post-labelling delays and/or using crusher gradients, 14 or by postprocessing methods. 31 Third, the other CBV-based implementations (see Appendix 1) are not affected by deconvolution-related errors (e.g. noise-sensitivity, errors associated with the regularization, bolus dispersion, sampling-related issues, etc). It could therefore be expected that using one of these other cases may provide more stable Hct measurements.
Fourth, errors related to PVEs in the underlying MRI images will translate to PVE-related errors in the calculated Hct tissue maps. The degree of PVE will depend on the particular implementation used. For example, Case 1 can be subject to considerable PVEs, given that ASL is limited to a relatively coarse spatial resolution. In contrast, the implementation described in Case 4 (see Appendix 1) has the greatest potential to minimise PVE, given that it does not rely on dynamic measurements and it is, therefore, more amenable to higher resolution acquisition. The use of the same spatial resolution for all MRI data involved is also preferable, to avoid introducing a differential PVE effect between the various maps used for Hct tissue quantification. This was, however, a limitation of the current study, which was based on retrospective data, and not on a protocol specifically designed for haematocrit mapping. Partial volume contamination could be minimised, in principle, using post-processing methods. For example, various PVE correction methods have been proposed for ASL. 32, 33 However, similar PVE correction methods are yet to be developed for DSC-MRI.
A further source of error in ASL is the coil sensitivity, which can introduce spatial intensity variations across the ASL results. This can be minimised by explicitly calculating the coil sensitivity profile, or by using a map as the calibration reference during quantitation. 23 ASL can be also influenced by errors in the assumed parameters in the ASL quantification model (e.g. k, T 1a , T Ã 2a ). It should be also noted that ASL quantification is not necessarily strictly Hct-independent, given the potential influence of Hct tissue on the assumed values for lambda and relaxation times.
It should be emphasised that errors in the underlying MRI measurements could have important consequence for the accuracy of Hct mapping when studying certain patient groups. For example, ASL applications to stroke and severe vascular disease are known to be highly sensitive to artefacts due to prolonged transit delays. 14 These errors will directly translate into errors on the cerebral Hct maps. For such clinical applications, the use of velocity-selective ASL 34 may provide a better ASL variant for the implementation of Case 1, given its known reduced transit delay sensitivity. Similarly, DSC-MRI perfusion measurements in these patient groups can be subject to bolus dispersion errors 35 ; the use of local AIF 36 may provide a solution to minimise this source of error. A further example of possible errors relates to applications in tumours, where contrast leakage effects must be taken into account in DSC-MRI quantification. 12 In the current study, we limited the quantitative analysis to grey matter structures. It should be noted that quantification of cerebral Hct in white matter is currently relatively unreliable. This is primarily due to the difficulties of quantifying CBF in white matter using ASL. 21 One of the CBV-based methods (especially Case 4 with CBV T1 ) should allow a better prospect for measuring white matter Hct. In fact, the Case 4 implementation, when combined with a blood pool contrast agent (e.g. gadofosveset), 37 may open up the possibility of mapping cerebral haematocrit with high spatial resolution and high signal-tonoise ratio.
We also had to assume a value for the arterial Hct, since no blood samples were available. Individual arterial Hct measurements should be of great benefit to properly account for the inter-subject variability in this parameter. For example, different arterial Hct values are seen in neonates and young children, as well as in some patient groups (e.g. patients with sickle-cell disease).
Future studies
A limitation of the current study is that data for only one of the implementations (Case 1) was available. Further work is required to compare the various implementations described here, and to determine their relative accuracy and precision, as well as their limitations. Further work is also required to optimise the acquisition protocols, particularly aimed at measuring cerebral Hct.
A validation of the proposed method could be achieved by comparing the measurements from this MRI approach to those obtained using more traditional invasive methods, such as PET or SPECT measurements in humans subjects, or quantitative autoradiography in animal experiments. However, such a validation is beyond the scope of this study.
Conclusion
A novel non-invasive approach to measure cerebral haematocrit using MRI was proposed. The method relies on combining measurements from two MRI techniques, one that provides Hct-dependent and another one with Hct-independent values. As proof-of-concept, the method was illustrated using DSC-MRI and ASL data on a group of healthy subjects, and was shown to measure cerebral Hct in general agreement with literature values, with good test-retest reproducibility. The proposed MRI method could have important applications in various neurological diseases, such as stroke and tumours. 
